Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease.
Journal: Ophthalmology and therapy
Published: February 11, 2026
Safety and Efficacy of Lotilaner Ophthalmic Solution (0.25%) in Treating Demodex Blepharitis: Pooled Analysis of Two Pivotal Trials.
Journal: Ophthalmology and therapy
Published: October 22, 2024
The impact of Demodex blepharitis on patient symptoms and daily life.
Journal: Optometry and vision science : official publication of the American Academy of Optometry
Published: March 28, 2024
Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study.
Journal: Cornea
Published: September 06, 2023
Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).
Journal: Ophthalmology
Published: January 13, 2023
Showing 1-5 of 5
Last Updated: 09/26/2026